[1]
Boyko, O. et al. 2023. Erythropoietin as an independent prognostic factor in myelodysplastic syndromes. Experimental Oncology. 43, 1 (May 2023), 41–45. DOI:https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-1.15914.